Thursday, March 02, 2017 12:35:40 AM
As Bitcoin ETF Nears, Analysts Warn of Trading Frenzy
Some predict a speculative rush if SEC approves a new fund in March
By ROB CURRAN THE WALL STREET JOURNAL
Feb. 5, 2017 10:10 p.m. ET
If the Securities and Exchange Commission approves a bitcoin exchange-traded fund next month, it might set off a speculative rush into bitcoin.
An easily accessed ETF that tracks the value of bitcoin could cause money to flood into the fledgling bitcoin market, analysts say. Indeed, what some see as a chance for average investors to participate in one of the great financial innovations of recent years could set off a trading frenzy in an already wild market.
“My concern is that the launch of an ETF could lead to irrational exuberance if the price of bitcoin appreciates dramatically,” says Christopher Burniske, blockchain-products lead at money manager and research firm ARK Investment Management. ARK invests in Bitcoin Investment Trust, an ETF-like fund that already trades over the counter but currently is only available to wealthy investors.
Winklevosses ready
After a nearly four-year wait, the SEC faces a deadline of March 11 to decide on a rule change that would allow the Winklevoss Bitcoin Trust ETF to trade on the Bats Global Market exchange.
Recent MGTI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 06:21:10 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/29/2023 05:15:26 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 12/22/2023 09:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/22/2023 09:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/22/2023 09:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 01:30:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/13/2023 04:29:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:27:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/27/2023 09:15:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM